Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine for Postoperative Analgesia in Children Undergoing Major Abdominal Cancer Surgery

NCT02861716 is registered in ClinicalTrials.gov with South Egypt Cancer Institute as lead sponsor.

NCT NCT02861716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02861716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine for Postoperative Analgesia in Children Undergoing Major Abdominal Cancer Surgery
Lead sponsor
South Egypt Cancer Institute
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2016
Completion date
December 31, 2019
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intrathecal dexmedetomidine, pediatric cancer surgery